Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder
22q11.2 deletion syndrome (22q11DS) is a risk factor for psychiatric illnesses, including schizophrenia and anxiety. Small studies have shown that several neuroleptic medications are effective in treating psychosis in this population, but are also associated with an increased risk of adverse effects...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-10-01
|
| Series: | Mental Illness |
| Subjects: | |
| Online Access: | http://www.pagepress.org/journals/index.php/mi/article/view/7225 |